Published in Genetics and Environmental Business Week, February 8th, 2007
"2006 was a year of significant evolution for Pharmion and set the stage for what we believe will be a transformational year in 2007," said Patrick J. Mahaffy, Pharmion's president and chief executive officer. "With three marketing authorization applications planned in Europe, survival data from two large randomized Phase III studies and the initiation of pivotal studies for two products we've most recently licensed, 2007 could represent a significant leap forward for our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.